Sensei Biotherapeutics Inc - ESG Rating & Company Profile powered by AI
The SDG score for Sensei Biotherapeutics Inc indicates the company's transparency towards the UN SDGs. This analysis of Sensei Biotherapeutics Inc is assembled by All Street Sevva using proprietary AI. Scroll down to the end of the webpage for potential risks for Sensei Biotherapeutics Inc based on sector, location and marketcap.
Sensei Biotherapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 2.7, social score of 0.0 and governance score of 6.0.
2.9
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1336 | SyneuRx International (Taiwan) Corp | 3.0 | Medium |
1336 | Sensorion SA | 3.0 | Medium |
1353 | Sensei Biotherapeutics Inc | 2.9 | Medium |
1353 | Caribou Biosciences Inc | 2.9 | Medium |
1353 | Checkmate Pharmaceuticals Inc | 2.9 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Sensei Biotherapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Sensei Biotherapeutics Inc disclose current and historical energy intensity?
Does Sensei Biotherapeutics Inc report the average age of the workforce?
Does Sensei Biotherapeutics Inc reference operational or capital allocation in relation to climate change?
Does Sensei Biotherapeutics Inc disclose its ethnicity pay gap?
Does Sensei Biotherapeutics Inc disclose cybersecurity risks?
Does Sensei Biotherapeutics Inc offer flexible work?
Does Sensei Biotherapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Sensei Biotherapeutics Inc disclose the number of employees in R&D functions?
Does Sensei Biotherapeutics Inc conduct supply chain audits?
Does Sensei Biotherapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Sensei Biotherapeutics Inc conduct 360 degree staff reviews?
Does Sensei Biotherapeutics Inc disclose the individual responsible for D&I?
Does Sensei Biotherapeutics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Sensei Biotherapeutics Inc disclose current and / or historical scope 2 emissions?
Does Sensei Biotherapeutics Inc disclose water use targets?
Does Sensei Biotherapeutics Inc have careers partnerships with academic institutions?
Did Sensei Biotherapeutics Inc have a product recall in the last two years?
Does Sensei Biotherapeutics Inc disclose incidents of discrimination?
Does Sensei Biotherapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Has Sensei Biotherapeutics Inc issued a profit warning in the past 24 months?
Does Sensei Biotherapeutics Inc disclose parental leave metrics?
Does Sensei Biotherapeutics Inc disclose climate scenario or pathway analysis?
Does Sensei Biotherapeutics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Sensei Biotherapeutics Inc disclose the pay ratio of women to men?
Does Sensei Biotherapeutics Inc support suppliers with sustainability related research and development?
Does Sensei Biotherapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Sensei Biotherapeutics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Sensei Biotherapeutics Inc involved in embryonic stem cell research?
Does Sensei Biotherapeutics Inc disclose GHG and Air Emissions intensity?
Does Sensei Biotherapeutics Inc disclose its waste policy?
Does Sensei Biotherapeutics Inc report according to TCFD requirements?
Does Sensei Biotherapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Sensei Biotherapeutics Inc disclose energy use targets?
Does Sensei Biotherapeutics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Sensei Biotherapeutics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Sensei Biotherapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the treatment of cancer; and SNS-401-NG, an ImmunoPhage vaccine targeting multiple tumor antigens. It has a collaboration with The University of Washington to research and develop Merkel cell carcinoma vaccine. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.